This content is machine translated DPP4 inhibitor in adolescents with type 1 diabetes Sitagliptin add on shows renoprotective effect Children with type 1 diabetes have an increased risk of developing diabetic kidney disease (DKD). Inhibition of dipeptidyl peptidase-4 (DPP4) has positive effects on various metabolic indicators in diabetes. Egyptian…
View Post 3 min This content is machine translated Adolescents with type 1 diabetes Metformin can improve subclinical atherosclerosis Neuregulin-4 (Nrg-4) may have anti-inflammatory and anti-atherogenic properties. Egyptian researchers used Nrg-4 together with carotid intima-media thickness as a marker for subclinical atherosclerosis. Their finding: The addition of metformin to…
View Post 5 min This content is machine translated Atopic dermatitis Patient training – also of great benefit to adults As atopic dermatitis (AD) is a chronic, relapsing skin disease, a long-term treatment strategy is required. While training programs for parents of affected children have long been established, it has…
View Post 6 min This content is machine translated Asthma update for the family doctor Diagnosis and treatment of adolescent patients The fact that asthma is a clinical diagnosis that can only be made by looking at all the findings together applies particularly to children and adolescents. Patients with rare asthma…
View Post 4 min This content is machine translated Difficult to treat asthma in adolescents Adherence and self-management insufficient About 10% of adolescent asthmatics have difficult-to-treat asthma. Poor adherence is a key problem in this age group and is largely responsible for poor symptom control. Early multidisciplinary management and…
View Post 8 min This content is machine translated Plaque psoriasis Updated guideline recommendations for children and adolescents Early treatment in children and adolescents with psoriasis is an important supply target. The updated s2k guideline provides evidence-based decision support for the selection of appropriate therapy. In the new edition…
View Post 4 min This content is machine translated Atopic dermatitis: biologics Dupilumab also effective and safe in under 12-year-olds In Switzerland, the approval of the highly effective biologic Dupilumab in the indication area of atopic dermatitis has so far been limited to adult and adolescent patients aged 12 years…
View Post 7 min This content is machine translated Psoriasis in childhood and adolescence Secukinumab in juvenile plaque psoriasis – sustained efficacy demonstrated Treatment options for psoriasis patients in childhood and adolescence are much more limited compared to the treatment spectrum for adults. But pediatric patients can also benefit from targeted treatment. This…
